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Abstract 
A novel technique for independent and simultaneous label-
ing of two antigens expressed on individual cells (referred to as 
mixed labeling) is presented. The staining procedure com-
bined three-step (streptavidin-biotin) immunogold-silver 
staining with three-step immunoenzymatic labeling. To ensure 
both high specificity and high sensitivity, particular emphasis 
was placed on designing a protocol that avoids immunological 
crossreactivity between the antibody reagents and overlap-
ping ofthe final color products. Two examples for usage ofthis 
mixed labeling technique are described: lymphocyte sub-
populations were identified in inflammatory lesions of human 
skin and infected host cells were characterized in the skin of 
mice infected with the obligatory intracellular parasite Leish-
mania major, a cause of human cutaneous leishmaniasis. (The 
J HistotechnoI16 :223, 1993) 
Key words: alkaline phosphatase, FITC-anti-FITC system, 
immunogold-silver staining, immunohistochemistry, label-
ing, leishmaniasis, mixed labeling, two color staining 
Introduction 
Various approaches have been successfully applied for 
studying the distribution of multiple antigens within one 
histological section. They are based on the successive perfor-
mance of two independent single labeling procedures with 
contrasting signals. Double immunoenzymatic labeling (IEL) 
or two-color immunofluorescence labeling have gained wide 
acceptance (1-3). However, both possibilities present imma-
nent, although different problems. 
Double IEL allows satisfactory antigen detection only as 
long as the molecules are expressed by different cells in the 
section. If the antigens are colocalized on the very same cell, 
mixing of the dyes finally obscures the individual single 
color signals. This mostly results in poor visibility of the less 
abundant antigen and impedes appropriate evaluation. Thus, 
mixed labeling with double IEL has not gained much appli-
cation. 
On the other hand, double immunofluorescence is a well-
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suited and widely used method for mixed labeling. Major 
disadvantages of immunofluorescence procedures are the 
fading of signals, different illumination and filter systems for 
viewing, invisibility of the general pathology during fluores-
cence microscopy, autofluorescence of tissue components, 
and a lower sensitivity than IEL. 
For these reasons, an alternative approach has been en-
visaged that avoids these disadvantages by combining immu-
nogold-silver staining (IGSS) with IEL (4-7). This article 
describes examples of mixed labeling procedure. For analy-
sis of lymphocyte sUbpopulations in human tissues, primary 
antibodies of the same species (mouse) that were either un-
conjugated or linked to fluorescein isothiocyanate (FITC) 
were used for staining the respective antigens. For analysis 
of immunocompetent cells in mouse tissues, primary anti-
bodies from different species were used for double staining. 
Materials and Methods 
Preparation of Tissue Sections 
For the mixed labeling technique, biopsy material from 
inflammatory lesions of human skin (eg, atopic dermatitis, 
chronic eczema) or skin lesions from mice infected with 
Leishmania major (a cause of human cutaneous leishmania-
sis) were used. Immediately after collection, the tissue sam-
ples were snap-frozen in cryomolds (Miles Scientific, Naper-
ville, IL) containing aCT compound (Miles Scientific) with 
isopentane precooled in liquid nitrogen or dry ice. Cryostat 
sections (4-8 /-tm) were cut at a temperature of -12°C to 
- 20°C and thawed onto adhesive slides. The adhesive was 
selected according to its lack of metal ions, which would inter-
fere with the silver enhancement procedure of the IGSS. 
Histostik (Accurate Chemical and Scientific, Westbury, NY) 
or 0.5 % gelatin solution without further additives were both 
suitable for coating the slides. For some tissues, it was suffi-
cient to thaw the sections onto slides that had been rinsed thor-
oughly with 25 % hydrochloric acid (HCl) . Subsequently, the 
sections were airdried and fixed in acetone ( -20°C, 10 min) . 
Before labeling, the sections were rinsed with phosphate 
buffered saline (PBS) to wash off OCT compound. Immedi-
ately thereafter, they were incubated in a skim milk solution 
(Blotto) with 20 % heat-inactivated sheep serum to avoid both 
nonspecific and specific background labeling. Blotto was pre-
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pared by vigorously stirring 5 % skim mild powder and 0.1 % 
Tween 20 into PBS and adjusting the pH to 7.4-7.6. Alterna-
tively, PBS containing 0.1 % bovine serum albumin (BSA), 
0.1 % gelatin and 0.1 % Tween 20 can be used for washing. To 
block nonspecific binding, this buffer was supplemented with 
20% heat-inactivated fetal calf serum (FCS) . 
Antibodies, Reagents, and Labeling 
Procedure for Human Tissues 
For the tissues examined in this paper, unconjugated mouse 
monoc1onal antibodies (MAbs) directed against CD45 
(Becton-Dickinson, Sunnyvale, CA) were used for detection 
ofthe first antigen, and FITC-conjugated mouse MAbs recog-
nizing CD3 (Becton-Dickinson) served for demonstration of 
the second antigen (8). However, a variety of other antibodies 
may be combined. As second- and third-step reagents (see also 
Figure 1 and staining procedure given below) , the following 
reagents are recommended: biotinylated anti-mouse immuno-
globulin (Ig) at 1:200 (Amersham, Amersham, UK), 
streptavidin -conjugated gold at 1: 30-1: 50 (Amersham) , silver 
enhancement mixture (Amersham), rabbit anti -FITC Ig (East 
Acres Chemicals, Southbridge, MA), alkaline phosphatase 
(AP)-conjugated goat anti-rabbit Ig at 1:200 (Accurate). Al-
ternative products from other manufacturers were equally 
suitable in our hands. The appropriate concentrations had to 
be adjusted carefully by checkerboard titrations. 
As suitable color substrates for the AP staining of human 
and mouse tissues, fast blue or new fuchsin (Sigma, St Louis, 
MO or Merck, Darmstadt, Germany) is recommended. 
Fast blue solution. Fast blue solution contained 0.2 mglml 
naphtol AS-MX phosphate (Sigma) dissolved in N ,N-di-
methylformamide (final concentration 2 %), 1 mM levamisole 
and 1 mglml fast blue BB salt in 0.1 M Tris-buffered saline 
buffer at pH 8.2 . 
New fuchsin solution. The new fuchsin substrate solution 
consisted of 0.5 mg/ml naphtol AS-BI phosphate (Sigma) dis-
solved in N ,N-dimethylformamide (final concentration 
0.5 %) , 6 mM sodium nitrite, 1 mM levamisole, and 4 % (w/v) 
new fuchsin (stock solution diluted in 2 M HCl) in Tris-
buffered saline (200 mM, pH 9.0) . The substrate solutions 
were filtered onto the slides and color development was 
stopped after 5-20 min. 
Staining Procedure (Figure 1) 
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1. Preincubate slides with Blotto containing 20 % sheep 
serum (blocking solution) at room temperature (RT) 








After removal of excess blocking solution (no wash-
ing!), incubate slides with first-step MAb at RT for 2 hr 
or, alternatively, at 4°C overnight. 
Rinse thoroughly with Blotto (X 3). 
Incubate slides with biotinylated sheep anti-mouse Ig 
at RT for 1 hr. 
Rinse thoroughly with Blotto (X 2) and then with PBS 
containing 5 % BSA and 0.1 % Tween 20. 
Incubate with streptavidin-conjugated gold at RT for 
1 hr. 
Rinse thoroughly with PBS/BSA/Tween 20 (X 2), and 
then with Blotto (X 2) . 
Block with Blotto containing 10 % normal mouse se-
rum at RT for 30 min to avoid binding of the FITC-
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Figure 1. Schematic presentation of the mixed labeling procedure with pri-
mary antibodies from the same species. The first antigen (Agl) , to be visual-
ized by lOSS, is detected by an unconjugated mouse antibody. The corre-
sponding biotiny lated secondary antibody has multiple spacer arms to avoid 
steric hindrance of the reaction with the tertiary reagent (gold-conjugated 
streptavidin). Size and signal of the gold particles (red squares) are enlarged 
by silver enhancement (red angles). The second antigen (Ag2), to be labeled 
by IEL, is detected by a FITC-conjugated antibody (FITC, yellow circles) , 
followed by rabbit anti-FITC 19 and AP-conjugated anti-rabbit 19 (AP, blue 
circles). 
conjugated mouse MAb to be applied in Step 9 to the bi-
otinylated anti-mouse Ig (see step 4). 
9. Incubate slides with FITC-conjugated mouse MAb 
directed against the second antigen to be demonstrated 
at RT for 2 hr or at 4°C overnight. 
10. Rinse thoroughly with Blotto (x 3). 
11. Incubate with rabbit anti-FITC Ig at RT for 1 hr. 
12. Rinse thoroughly with Blotto (X 3) . 
13. Incubate with AP-conjugated goat (or sheep) anti-
rabbit Ig at RT for 1 hr. 
14. Rinse thoroughly with Blotto (x 3) . 
15. Incubate with AP-specific substrates (fast blue or new 
fuchsin solutions) . Monitor the AP-substrate reaction 
under a microscope for optimal signal to noise ratio. 
Stop the enzyme reaction by rinsing with Blotto. 
16. Rinse with distilled water (D/W) . 
17. Visualize immunogold labeling by incubation of slides 
with silver-enhancement mixture until the desired sig-
nal intensity has developed (2-5 incubation periods of 
3-10 min each). Rinse thoroughly with D/W between 
the incubation periods. 
18. Rinse thoroughly with D/W. 
19. Counterstain with non-interfering dyes (eg, nuclear 
fast red) and mount. 
20. Evaluate sections with brightfield and epipolarization 
microscopy (the latter results in clear and sensitive 
demonstration of IGSS). 
Antibodies, Reagents, and Labeling 
Procedure for Mouse Tissues 
For the experiments depicted in this study, a rabbit serum 
raised against L. major was used for demonstration of the first 
antigen. Rat MAbs to non-lymphoid dendritic cells (NLDC-
145) served for identification of the second antigen on this par-
ticular type of host cell (9). As secondary and tertiary re-
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agents, the following material was used: biotin-conjugated 
mouse anti-rat Ig (Dianova, Hamburg, Germany) at 1:500; 
gold-conjugated goat anti-rabbit antibodies (Dako, Hamburg, 
Germany) at 1:100; streptavidin-biotin AP complex (Dako); 
fast blue solution as substrate for AP; and immunogold-silver 
enhancement mixture for visualization ofIGSS. 
Staining Procedure 
1. Rinse slides with Blotto. Follow by preincubation with 
Blotto containing 20 % sheep serum or FCS at RT for 
20 min. 
2. After washing in Blotto, incubate sections with a mix-
ture of both primary antibodies (eg, rabbit anti-L. ma-
jor antiserum and monoclonal rat anti -NLDC antibod-
ies) at RT for 2 hr or, alternatively, at 4°C overnight. 
3. Rinse thoroughly with Blotto (X 3). 
4. Incubate sections with gold-conjugated anti-rabbit an-
tibodies at RT for 1 hr. 
5. Rinse thoroughly with Blotto (X 3). 
6. Block with Blotto containing 20 % normal rabbit serum 
at lIT for 30 min. 
7. Rinse thoroughly with Blotto (x 3). 
8. Incubate sections with biotinylated anti-rat Ig antibod-
ies at RT for 1 hr. 
9. Rinse thoroughly with Blotto (x 3) . 
10. Incubate sections with streptavidin-biotin AP complex 
at RT for 1 hr. 
11. Rinse thoroughly with Blotto (x 3) . 
12. Apply fast blue solution and incubate until the desired 
color intensity has developed. Rinse with Blotto to stop 
the reaction. 
13. Rinse briefly with D/W 
14. Incubate slides with PBS containing 2 % glutaralde-
hyde at 4°C for 10 min (postfixation). 
15. Rinse briefly with D/W 
16. Incubate slides with PBS containing 50 mM glycine at 
4°C for 10 min for quenching endogenous AP activity. 
Note: Steps 14-16 may also be included in the protocol 
for labeling human tissue. 
17. Rinse briefly with D/W 
18. Apply immunogold-silver enhancement mixture and 
incubate until the desired signal intensity has devel-
oped (2-5 incubation periods of 3-10 min each). 
Rinse thoroughly with D/W between the incubation 
periods. 
19. Rinse thoroughly with D/W 
20. Counterstain with nuclear fast red and mount. 
Optimal Concentration Detennination 
Prior to combining IGSS with IEL, the optimal concentra-
tion of the relevant antibodies and reagents were worked out by 
checkerboard titration with the respective single color stains. 
Subsequently, the mixed labeling procedure was performed 
for simultaneous detection of two antigens with a partly over-
lapping expression pattern . 
Results 
Figure 2A shows an example of a human skin section that 
was stained for the T cell-associated antigen CD3 (IEL, blue) 
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Figure 2. Double staining for CD45 RA (IGSS) and CD3 (AP labeling 
with naphthol AS-MX/fast blue) in a section of human skin with chronic 
inflammation. (A) Under brightfield illumination, the brown cells were 
CD45RA + CD3-, whereas the dark blue cells were double positive 
(CD45RA + CD3+) . (B) This is verified under epipolarization illumination, 
which exclusively showed the immunogold silver-labeled CD45RA + cells. 
Original magnification x 1,000. 
and for the leukocyte common antigen CD45 (lGSS, brown). 
Under epipolarization illumination (Figure 2B), IGSS single-
labeled cells displayed yellow bright grains, whereas cells ad-
ditionally stained by IEL showed a shift towards a bright bluish 
color. In Figure 3A, an example is depicted of a mouse skin 
section stained for non-lymphoid dendritic cells (lEL, blue) 
and for the obligatory intracellular protozoan parasite L. ma-
jor (IGSS, brown). The skin is heavily infiltrated by parasites 
(Figure 3B) , some of which are localized within dendritic 
cells (10). 
Discussion 
The presented protocols for simultaneous demonstration of 
two tissue antigens are based on comprehensive studies with a 
large series of combinations ofIGSS and IEL (7). The sensi-
tivity of a three-step IGSS is three- to five-fold lower than that 
of a three-step IEL. Consequently, mixed labeling was started 
with IGSS and followed by IEL because the detection of the 
second antigen in double labeling procedures is generally as-
sociated with a reduced sensitivity. This sequence of double 
labeling posed some restrictions on the choice of reagents to be 
utilized for the IEL procedure. In general, peroxidase labeling 
with the substrates 3-amino-9-ethy1carbazole (AEC) or di-
aminobenzidine (DAB) displays a higher sensitivity than AP 
labeling and is, therefore, used more frequently. The red end 
product of the substrate AEC, in contrast to the brown reaction 
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Figure 3. Double labeling for identification of parasitized cells in the skin 
of mice infected with L. major. (A) The obligatory intracellular parasites 
were labeled with IGSS (brown) and the host cells (non-lymphoid dendritic 
cells detected by rat MAbs NLDC-14S) were identified by AP labeling with 
naphthol AS-MX phosphate/fast blue as substrate; brightfield illumination. 
(B) The distribution of parasite antigen was visible under epipolarization 
illumination. Original magnification x 1,000. 
product of DAB, would contrast well with IGSS under 
brightfield illumination. However, our earlier studies showed 
that peroxidase labeling is incompatible with IGSS (7). The 
silver enhancement procedure resulted in nonspecific silver 
grain precipitation on the AEC end product. On the other 
hand, performance of the substrate reaction after silver en-
hancement prevented the reflection of silver-enhanced gold 
particles under epipolarization illumination. 
For these reasons, AP labeling appears to be better suited 
for mixed labeling. Nevertheless, the substrate-chromogen 
reagents have to be selected carefully. We have previously 
shown that the reaction product of naphthol AS-MX phos-
phate/fast red reflects polarized incident light in a way similar 
to IGSS and that the substrate bromochloro-indolyl-phos-
phate/nitro blue tetrazolium is poorly discernible from IGSS 
under brightfield illumination (7). Therefore, only the sub-
strates naphthol AS-MX phosphate/fast blue (Figure 2) and 
naphthol AS-BI phosphate/new fuchsin seem to be appropri-
ate for mixed labeling combining IEL and IGSS. They do not 
interfere with and can be easily discriminated from IGSS. 
Multistep procedures strongly amplify the reactions of the 
primary antibodies with the respective tissue antigens and 
result in a high sensitivity. However, if it is not possible to 
use primary antibodies from different species, undesired 
reactions may occur between the various Igs. This cross-
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reactivity can be drastically reduced by using hapten-coupled 
antibodies (such as FITC-conjugated MAbs for detection of 
the second antigen) and the corresponding hapten-specific Ig 
(8) . Such a technique allows the independent detection of two 
tissue antigens with MAbs derived from the same species 
(eg, combining unconjugated and hapten-conjugated mouse 
MAbs). In addition to antibody conjugation with FITC, sul-
fonation or coupling with digoxigenin may be utilized. FITC 
offers major advantages because a large variety of FITC-
linked antibodies are commercially available, and FITC con-
jugation can be achieved with standard protocols. We have 
shown an example of mixed labeling via the FITC/anti-FITC-
system (Figure 2) . In the other example, crossreactivity was 
prevented by using primary antibodies from different species 
(Figure 3) . An advantage of the latter technique is the time-
saving possibility of simultaneous application of both pri-
mary antibodies. 
When FITC-conjugated antibodies and anti-FITC Ig are 
used for detection of the second antigen, there is only one 
possibility for crossreactivity that should be kept in mind: af-
ter completion of the first-step staining (Figure 1), the bi-
otinylated sheep anti-mouse Ig used as secondary reagent 
may still have free binding sites. Thus, the FITC-linked anti-
body for detection of the second antigen may be nonspe-
cifically trapped . This can be minimized by optimal dilution 
of the biotin-conjugated anti-mouse Ig and, of even greater 
importance, by blocking with normal mouse serum before 
starting with the second-step staining. 
The described protocols for mixed labeling with a combi-
nation of IEL and IGSS offer a method which allows the 
highly specific and sensitive labeling of shared epitopes. In 
addition to the immunological characterization of cells, the 
method is well suited for such other fields of research as neu-
roscience, cell biology, and tumor biology. 
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